Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model

被引:30
作者
Rogowski, O
Shapira, I
Zimran, A
Zeltser, D
Elstein, D
Attias, D
Bashkin, A
Berliner, S
机构
[1] Shaare Zedek Med Ctr, Gaucher Clin, IL-91031 Jerusalem, Israel
[2] Shaare Zedek Med Ctr, Dept Med, IL-91031 Jerusalem, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Dept Med D, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
关键词
inflammation; Gaucher disease; ESR; fibrinogen; hs-CRP;
D O I
10.1016/j.bcmd.2004.08.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with Gaucher disease, perhaps due to chronic storage of glycolipids, apparently harbor a subclinical or underlying inflammation. Quantification of a baseline inflammatory profile in patients with Gaucher disease is more impressive when compared with that of matched healthy controls in a systematic, automated fashion. A mean of 16 healthy controls was generated for each of 50 patients with Gaucher disease by applying variables relating to potential for inflammatory features, for example, atherothrombotic risk factors. Relative to matched controls, male patients with Gaucher disease had significant elevations in fibrinogen (312 +/- 61 vs. 244 +/- 21 mg/dl; P = 0.002), accelerated erythrocyte sedimentation rate (ESR) (21.5 +/- 16.1 vs. 7.0 +/- 1.4 mm/H; P = 0.004), and elevated high-sensitivity C-reactive protein (hs-CRP) (1.4 +/- 2.4 vs. 0.9 +/- 1.6 mg/l; P = 0.026). Comparison of female patients versus controls revealed significant elevations in fibrinogen (337 +/- 81 vs. 273 +/- 19 mg/dl; P < 0.0005) and accelerated erythrocyte sedimentation rate (33.1 +/- 22.2 vs. 15.6 +/- 3.1 mm/H; P < 0.0005). Enzyme replacement therapy for Gaucher disease did not affect these values. Comparison with the matched healthy controls highlights the true low-grade inflammatory profile in Gaucher disease. By employing information from well-matched controls, even low-grade inflammatory conditions that may have otherwise been considered "within normal limits" can be teased out. This approach is not disease-specific and can be easily applied to any acute or subacute inflammatory disease/condition. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:26 / 29
页数:4
相关论文
共 26 条
[11]   Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease [J].
Hollak, CEM ;
Evers, L ;
Aerts, JMFG ;
vanOers, MHJ .
BLOOD CELLS MOLECULES AND DISEASES, 1997, 23 (11) :201-212
[12]  
*INT COMM STAND HE, 1965, IMMUNOCHEMISTRY, V2, P235
[13]   Statins as potent antiinflammatory drugs [J].
Lefer, DJ .
CIRCULATION, 2002, 106 (16) :2041-2042
[14]   Inflammation and atherosclerosis [J].
Libby, P ;
Ridker, PM ;
Maseri, A .
CIRCULATION, 2002, 105 (09) :1135-1143
[15]   Cytokine mRNA in Gaucher disease [J].
Lichtenstein, M ;
Zimran, A ;
Horowitz, M .
BLOOD CELLS MOLECULES AND DISEASES, 1997, 23 (19) :395-401
[16]   Measuring plasma fibrinogen to predict stroke and myocardial infarction - An update [J].
Maresca, G ;
Di Blasio, A ;
Marchioli, R ;
Di Minno, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (06) :1368-1377
[17]   Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease [J].
Michelakakis, H ;
Spanou, C ;
Kondyli, A ;
Dimitriou, E ;
VanWeely, S ;
Hollak, CEM ;
VanOers, MHJ ;
Aerts, JMFG .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1996, 1317 (03) :219-222
[18]   Reduction in C-reactive protein through cardiac rehabilitation and exercise training [J].
Milani, RV ;
Lavie, CJ ;
Mehra, MR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (06) :1056-1061
[19]   C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events [J].
Ridker, PM ;
Buring, JE ;
Cook, NR ;
Rifai, N .
CIRCULATION, 2003, 107 (03) :391-397
[20]   C-reactive protein - A simple test to help predict risk of heart attack and stroke [J].
Ridker, PM .
CIRCULATION, 2003, 108 (12) :E81-E85